These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 24774073)

  • 1. β-Hydroxy-β-methylbutyrate facilitates PI3K/Akt-dependent mammalian target of rapamycin and FoxO1/3a phosphorylations and alleviates tumor necrosis factor α/interferon γ-induced MuRF-1 expression in C2C12 cells.
    Kimura K; Cheng XW; Inoue A; Hu L; Koike T; Kuzuya M
    Nutr Res; 2014 Apr; 34(4):368-74. PubMed ID: 24774073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes.
    Wang DT; Yin Y; Yang YJ; Lv PJ; Shi Y; Lu L; Wei LB
    Int Immunopharmacol; 2014 Apr; 19(2):206-13. PubMed ID: 24534773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Hydroxy-β-methyl Butyrate Is More Potent Than Leucine in Inhibiting Starvation-Induced Protein Degradation in C2C12 Myotubes.
    Duan Y; Li F; Guo Q; Wang W; Zhang L; Wen C; Chen X; Yin Y
    J Agric Food Chem; 2018 Jan; 66(1):170-176. PubMed ID: 29227681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
    Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy.
    Aversa Z; Alamdari N; Castillero E; Muscaritoli M; Rossi Fanelli F; Hasselgren PO
    Biochem Biophys Res Commun; 2012 Jul; 423(4):739-43. PubMed ID: 22705301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats.
    Sheriff S; Kadeer N; Joshi R; Friend LA; James JH; Balasubramaniam A
    Mol Cell Endocrinol; 2012 Apr; 351(2):286-95. PubMed ID: 22266196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle fibre type-dependent effects of atorvastatin on the PI3K/Akt/mTOR signalling pathway and atrophy-related genes in rats.
    Gawedzka A; Knapik-Czajka M; Drag J; Belczyk M; Radwanska E; Adamek D
    Mol Biol Rep; 2024 Oct; 51(1):1062. PubMed ID: 39419905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Hydroxy-β-methylbutyrate (HMB) normalizes dexamethasone-induced autophagy-lysosomal pathway in skeletal muscle.
    Girón MD; Vílchez JD; Shreeram S; Salto R; Manzano M; Cabrera E; Campos N; Edens NK; Rueda R; López-Pedrosa JM
    PLoS One; 2015; 10(2):e0117520. PubMed ID: 25658432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
    Mirza KA; Pereira SL; Voss AC; Tisdale MJ
    Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
    Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
    Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
    Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate.
    Eley HL; Russell ST; Tisdale MJ
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1409-16. PubMed ID: 18854427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
    Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine Regulates Protein Turnover by Activating Protein Kinase B/Mammalian Target of Rapamycin and by Inhibiting MuRF1 and Atrogin-1 Gene Expression in C2C12 Myoblasts.
    Sun K; Wu Z; Ji Y; Wu G
    J Nutr; 2016 Dec; 146(12):2461-2467. PubMed ID: 27798331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Hydroxy β-methylbutyrate improves dexamethasone-induced muscle atrophy by modulating the muscle degradation pathway in SD rat.
    Noh KK; Chung KW; Choi YJ; Park MH; Jang EJ; Park CH; Yoon C; Kim ND; Kim MK; Chung HY
    PLoS One; 2014; 9(7):e102947. PubMed ID: 25032690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
    Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
    Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate.
    Eley HL; Russell ST; Tisdale MJ
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1417-26. PubMed ID: 18840762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.